P-gp expression as a possible marker for response to cisplatin/epirubicin as first line treatment in advanced ovarian cancer
M. Baekelandt(Norwegian Cancer Society), C. Tropé(Norwegian Cancer Society), Gunnar B. Kristensen(Oslo University Hospital), Ruth Holm(University of Aleppo), J M Nesland
Cited by 3
Related Papers
Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome.
|PubMed|1993|589
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
|PLoS ONE|2011|222
Prognostic significance of TP53 alterations in breast carcinoma
|British Journal of Cancer|1993|168